Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | renin | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin X | renin | 406 aa | 352 aa | 26.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Mycobacterium ulcerans | adenosine deaminase | 0.0654 | 1 | 0.5 |
Leishmania major | adenine aminohydrolase | 0.0654 | 1 | 1 |
Echinococcus granulosus | adenosine deaminase | 0.0654 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase 2, putative | 0.0213 | 0.0816 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Trypanosoma brucei | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 0.5563 | 0.5169 |
Trypanosoma cruzi | adenosine monophosphate deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Plasmodium falciparum | adenosine deaminase | 0.0654 | 1 | 1 |
Onchocerca volvulus | Adenosine deaminase homolog | 0.0654 | 1 | 1 |
Schistosoma mansoni | adenosine deaminase-related | 0.0654 | 1 | 1 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0654 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 0.5563 | 0.5169 |
Echinococcus multilocularis | adenosine deaminase | 0.0654 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0654 | 1 | 1 |
Plasmodium vivax | adenosine deaminase, putative | 0.0654 | 1 | 1 |
Mycobacterium tuberculosis | Probable adenosine deaminase Add (adenosine aminohydrolase) | 0.0654 | 1 | 0.5 |
Schistosoma mansoni | adenosine deaminase | 0.0654 | 1 | 1 |
Treponema pallidum | adenosine deaminase | 0.0654 | 1 | 0.5 |
Trichomonas vaginalis | adenosine deaminase, putative | 0.0654 | 1 | 0.5 |
Trypanosoma cruzi | adenosine monophosphate deaminase-like protein, putative | 0.0213 | 0.0816 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 0.5563 | 0.5169 |
Trypanosoma brucei | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0654 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0441 | 0.5563 | 0.5169 |
Loa Loa (eye worm) | hypothetical protein | 0.0654 | 1 | 1 |
Trypanosoma brucei | adenosine monophosphate deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Schistosoma mansoni | AMP deaminase | 0.0213 | 0.0816 | 0.0816 |
Mycobacterium leprae | Probable adenosine deaminase Add (ADENOSINE AMINOHYDROLASE) | 0.0654 | 1 | 0.5 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Entamoeba histolytica | adenosine deaminase, putative | 0.0654 | 1 | 1 |
Trypanosoma cruzi | AMP deaminase, putative | 0.0213 | 0.0816 | 0.5 |
Toxoplasma gondii | Adenosine/AMP deaminase domain-containing protein | 0.0654 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.7 nM | Inhibitory activity against purified human plasma renin at pH 6.0 | ChEMBL. | 2657067 |
IC50 (binding) | = 0.7 nM | Inhibitory activity against purified human plasma renin at pH 6.0 | ChEMBL. | 2657067 |
IC50 (binding) | = 7.6 nM | Inhibitory activity against human plasma renin at pH 7.4 | ChEMBL. | 2657067 |
IC50 (binding) | = 7.6 nM | Inhibitory activity against human plasma renin at pH 7.4 | ChEMBL. | 2657067 |
Solubility | = 0.023 mg ml-1 | Solubility of the compound in pH 6.5 buffer | ChEMBL. | 2657067 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.